BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 356740)

  • 1. Immunofluorescence of biopsy specimens: comparison of methods of transportation.
    Nisengard RJ; Blaszczyk M; Chorzelski T; Beutner E
    Arch Dermatol; 1978 Sep; 114(9):1329-32. PubMed ID: 356740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of dermatitis herpetiformis by an avidin-biotin-peroxidase method.
    Zaenglein AL; Hafer L; Helm KF
    Arch Dermatol; 1995 May; 131(5):571-3. PubMed ID: 7741544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemphigus and other diseases. Results of indirect intercellular immunofluorescence.
    Anderson HJ; Newcomer VD; Landau JW; Rosenthal LH
    Arch Dermatol; 1970 May; 101(5):538-46. PubMed ID: 4910380
    [No Abstract]   [Full Text] [Related]  

  • 4. Update on immunofluorescent testing in bullous diseases and lupus erythematosus.
    Gately LE; Nesbitt LT
    Dermatol Clin; 1994 Jan; 12(1):133-42. PubMed ID: 8143377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous immunofluorescence.
    Izuno GT
    Clin Lab Med; 1986 Mar; 6(1):85-102. PubMed ID: 3514099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of C3d and C4d immunohistochemistry on formalin-fixed tissue as a diagnostic adjunct in the assessment of inflammatory skin disease.
    Magro CM; Dyrsen ME
    J Am Acad Dermatol; 2008 Nov; 59(5):822-33. PubMed ID: 19119098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of immunoglobulin deposits in paraffin embedded skin with the peroxidase-antiperoxidase (PAP) method].
    Kutzner H; Kutzner U
    Hautarzt; 1986 Sep; 37(9):503-6. PubMed ID: 2945801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunohistological studies of immune dermatoses on reconstituted paraffin sections. Value and comparison of different methods].
    Kuhn A; Mahrle G; Steigleder GK
    Hautarzt; 1988 Jun; 39(6):351-4. PubMed ID: 3403272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic importance of immunofluorescence in oral bullous diseases and lupus erythematosus.
    Nisengard RJ; Jablonska S; Beutner EH; Shu S; Chorzelski TP; Jarzabek M; Blaszczyk M; Rzesa G
    Oral Surg Oral Med Oral Pathol; 1975 Sep; 40(3):365-75. PubMed ID: 1101128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune bullous dermatoses: a review.
    PatrĂ­cio P; Ferreira C; Gomes MM; Filipe P
    Ann N Y Acad Sci; 2009 Sep; 1173():203-10. PubMed ID: 19758152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of paraffin-processed tissue and the immunoperoxidase technique in the diagnosis of bullous diseases, lupus erythematosus and vasculitis.
    Turbitt ML; Mackie RM; Young H; Campbell I
    Br J Dermatol; 1982 Apr; 106(4):411-7. PubMed ID: 7041947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies in cutaneous immunofluorescence. I. The effect of storage time on direct immunofluorescence of skin biopsies from bullous disease and lupus erythematosus.
    Mackie RM; Young H; Campbell IA
    J Cutan Pathol; 1980 Aug; 7(4):236-43. PubMed ID: 7000865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic lupus erythematosus with vesiculobullous lesions. Immunoelectron microscopic studies.
    Tani M; Shimizu R; Ban M; Murata Y; Tamaki A
    Arch Dermatol; 1984 Nov; 120(11):1497-501. PubMed ID: 6388508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uses for immunofluorescence tests of skin and sera. Utilization of immunofluorescence in the diagnosis of bullous diseases, lupus erythematosus, and certain other dermatoses.
    Arch Dermatol; 1975 Mar; 111(3):371-81. PubMed ID: 1091215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Skin disease and immunofluorescence.
    Med J Aust; 1973 Sep; 2(12):571-2. PubMed ID: 4592290
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnostic problems associated with the coincidence of bullous dermatosis and lupus erythematosus visceralis. Demonstration of a case with Duhring's dermatitis herpetiformis in association with visceral lupus erythematosus].
    Meyer A; Jenni C; Krebs A
    Dermatologica; 1976; 153(1):57-64. PubMed ID: 791717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of immunofluorescence in the diagnosis of bullous diseases, lupus erythematosus, and other skin diseases. Cooperative study].
    Ann Dermatol Syphiligr (Paris); 1975; 102(4):363-84. PubMed ID: 1108757
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of immunofluorescence in dermatology].
    Holubar K
    Z Haut Geschlechtskr; 1970 Feb; 45(3):113-20. PubMed ID: 4911829
    [No Abstract]   [Full Text] [Related]  

  • 19. The presence of anti-basement membrane zone antibodies in the sera of patients with non-bullous lupus erythematosus.
    Ishikawa O; Zaw KK; Miyachi Y; Hashimoto T; Tanaka T
    Br J Dermatol; 1997 Feb; 136(2):222-6. PubMed ID: 9068736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous pemphigoid and dermatitis herpetiformis. Histopathologic differentiation of bullous pemphigoid and dermatitis herpetiformis.
    Eng AM; Moncada B
    Arch Dermatol; 1974 Jul; 110(1):51-7. PubMed ID: 4608882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.